Skip to main content

Benitec Wins Chinese Patent on Expressed RNAi HCV Therapy

Premium

Benitec announced this week that it has received a Chinese patent covering the use of its expressed RNAi constructs against hepatitis C.

According to the company, the patent covers an expression cassette the encodes two of the RNAi molecules used in the HCV treatment under development by partner Tacere Therapeutics. Other sequences, including the third employed in Tacere's drug, will be the subject of separate patent applications, Benitec said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.